Meiji Holdings Co Ltd
2269: XTKS (JPN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|$d | LOCK|Y%#c | LOCK|?vTVv& |
Meiji Earnings: Pricing Power Supports Higher Growth Outlook; Fair Value Up 3%
In the first quarter of fiscal 2026, ending March 2027, Meiji's domestic food revenue grew 4% year over year, while pharmaceutical margin improved to 15.2% from 9.8%, on 13.6% growth. Management maintained guidance and announced plans to restructure its China portfolio.
